Home › Research › Lewy body dementia
Survival rates in frontotemporal dementia and Alzheimer’s disease
David Foxe, James Muggleton, Sau Chi Cheung, Nicole Mueller, Rebekah M. Ahmed, Manisha Narasimhan, James R. Burrell, Yun Tae Hwang et al.. Neurodegenerative Disease Management, 2025-07-02
Topic: Risk, prevention and care in population studies
Plain-language summary
Median survival from symptom onset was longest in SD (11.9 years) and shortest in LPA (7 years). Median survival for the bvFTD, PNFA, and AD groups was 8.7, 8.6, and 10 years, respectively. SD survival was significantly longer than PNFA and AD. Female sex was associated with shorter survival in LPA. Shorter symptom duration at baseline assessment was related to shorter survival in bvFTD, SD, LPA, and AD. Lower overall cognition in bvFTD, LPA, and AD, and worse functional outcomes in SD and AD at baseline were associated with shorter survival. Our findings demonstrate distinct survival patterns across FTD and AD subtypes. Demographic and presenting clinical features provide valuable prognostic insights for survival.
What this study adds
Evidence grade: Low
Median survival from symptom onset differed across frontotemporal dementia and Alzheimer's disease subtypes, ranging from 7 years in LPA to 11.9 years in SD. Demographic and presenting clinical features provide valuable prognostic insights for survival.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Foxe, D., Muggleton, J., Cheung, S. C., Mueller, N., Ahmed, R. M., Narasimhan, M., et al. (2025). Survival rates in frontotemporal dementia and Alzheimer’s disease. Neurodegenerative Disease Management. https://doi.org/10.1080/17582024.2025.2527553
Vancouver
Foxe D, Muggleton J, Cheung SC, Mueller N, Ahmed RM, Narasimhan M, et al. Survival rates in frontotemporal dementia and Alzheimer’s disease. Neurodegenerative Disease Management. 2025. doi:10.1080/17582024.2025.2527553. PMID: 40600814.
BibTeX
@article{foxe2025-40600814,
author = {Foxe, David and Muggleton, James and Cheung, Sau Chi and Mueller, Nicole and Ahmed, Rebekah M. and Narasimhan, Manisha and Burrell, James R. and Hwang, Yun Tae and others},
title = {{Survival rates in frontotemporal dementia and Alzheimer’s disease}},
journal = {Neurodegenerative Disease Management},
year = {2025},
doi = {10.1080/17582024.2025.2527553},
pmid = {40600814},
url = {https://doi.org/10.1080/17582024.2025.2527553}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Median survival from symptom onset was longest in SD (11.9 years) and shortest in LPA (7 years).
- Median survival for the bvFTD, PNFA, and AD groups was 8.7, 8.6, and 10 years, respectively.
- SD survival was significantly longer than PNFA and AD.
- Female sex was associated with shorter survival in LPA.
- Shorter symptom duration at baseline assessment was related to shorter survival in bvFTD, SD, LPA, and AD.
Why it matters
Median survival from symptom onset differed across frontotemporal dementia and Alzheimer's disease subtypes, ranging from 7 years in LPA to 11.9 years in SD. Demographic and presenting clinical features provide valuable prognostic insights for survival.
Study details
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neurodegenerative Disease Management) |
| Journal's citation record | 0 / 4 | Neurodegenerative Disease Management: journal h-index 47 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 4.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Olivier Piguet: h-index 76 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | The University of Sydney: institution h-index 1,466 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40600814) |
| Free to read | 2 / 2 | Free to read |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1080/17582024.2025.2527553
- PubMed: 40600814
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Lewy body dementia from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.